Suchergebnisse - "Faries, Mark B."

PubPharm (314)

31

An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma

enthalten in: Annals of surgical oncology | 2022

von Shannon, A. | Straker, R. | Carr, M. | +17

32

Quantitative Nodal Burden and Mortality Across Solid Cancers

enthalten in: Journal of the National Cancer Institute | 2022

von Nguyen, A. | Luu, M. | Nguyen, V. | +15

33

Immunohistochemistry for Preferentially Expressed Antigen in Melanoma in the Differential Diagnosis of Melanocytic Lesions of the Nail Apparatus

enthalten in: The American Journal of dermatopathology | 2022

von Krajisnik, A. | Gharavi, N. | Faries, M. | +4

34

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma : Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

enthalten in: Annals of surgical oncology | 2022

von van Akkooi, A. | Hieken, T. | Burton, E. | +39

ErratumIn: Ann Surg Oncol. 2022 Apr 15;:. - PMID 35426590

35

Sentinel lymph node melanoma metastases : Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2022

von Cochran, A. | Wen, D. | Huang, R. | +19

36

ASO Visual Abstract: Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in MSLT-II

enthalten in: Annals of surgical oncology | 2022

von Jakub, J. | Lowe, M. | Harrison Howard, J. | +21

37

ASO Visual Abstract: Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in MSLT-II

enthalten in: Annals of surgical oncology | 2022

von Jakub, J. | Lowe, M. | Harrison Howard, J. | +21

38

Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

enthalten in: Annals of surgical oncology | 2022

von Jakub, J. | Lowe, M. | Howard, J. | +21

39

Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

enthalten in: Annals of surgical oncology | 2022

von Jakub, J. | Lowe, M. | Howard, J. | +21

40

Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)

enthalten in: Annals of surgical oncology | 2022

von Jakub, J. | Lowe, M. | Howard, J. | +21